Research into haemostatic dressings has proven that Celox was the only one that demonstrated a statistically significant increase in patient survival overall of roughly seven per cent, whereas neither Hemcon or Quikclot demonstrated any statistically significant increase in survival rate.
Trident Health and Safety has always recommended and supplied Celox based on experience; and will continue to do so now armed with research to prove it. For more information, take a look:
https://www.adsadvance.co.uk/research-paper-identifies-most-effective-haemostat.html
For more information, or if you require training in the use of Celox, contact us today at info@tridenthealthandsafety.co.uk
